Form 4: Novanta Director Converts RSUs, Receives New Grant
Insider Transaction Report
Novanta Inc. Director Robert Matthew Johnson converted 1,325 Restricted Stock Units into common shares and received a new grant of 1,799 RSUs.
Summary
- Director Robert Matthew Johnson acquired 1,325 shares of Novanta Inc. common stock on January 2, 2026.
- This acquisition resulted from the settlement of 1,325 previously granted Restricted Stock Units (RSUs).
- Johnson's direct beneficial ownership of Novanta Inc. common stock increased to 2,143 shares following this transaction.
- He also received a new grant of 1,799 Restricted Stock Units on January 2, 2026.
- These new RSUs are fully vested and non-forfeitable, entitling him to receive common shares on the first anniversary of the grant date.
Sentiment
Score: 7
Explanation: The transaction is a routine insider equity compensation event, indicating continued director involvement and alignment with shareholder interests, which is generally positive or neutral. No negative implications are apparent from this disclosure.
Positives
- Director Robert Matthew Johnson increased his direct beneficial ownership of Novanta Inc. common stock by 1,325 shares, demonstrating continued alignment with shareholder interests.
- The grant of 1,799 new, fully vested, and non-forfeitable Restricted Stock Units indicates ongoing compensation and retention of a key director.
Future Outlook
The newly granted 1,799 Restricted Stock Units are expected to settle into Novanta Inc. common shares on the first anniversary of the grant date, which is January 2, 2027, or the next business day if January 2, 2027, is not a business day.
Industry Context
This transaction represents a standard equity compensation event for a director, common across publicly traded companies to align management and director interests with shareholders. Such grants are a routine component of executive and director compensation packages in the technology and industrial sectors.
Comparison to Industry Standards
- The use of Restricted Stock Units (RSUs) for director compensation is a widespread practice among publicly traded companies, including peers in the industrial technology sector such as Cognex Corporation or Keyence Corporation.
- The structure of the RSU grant, including vesting and settlement terms, is consistent with typical equity incentive plans designed to retain talent and align long-term interests.
Stakeholder Impact
- Shareholders: The transaction increases a director's direct ownership of common stock and provides future equity incentives, which generally aligns the director's interests more closely with those of shareholders.
- Employees: No direct impact on general employees is indicated by this filing.
Next Steps
- The 1,799 new Restricted Stock Units are expected to settle into Novanta Inc. common shares on the first anniversary of the grant date (January 2, 2027, or the next business day).
Key Dates
| Date | Description |
|---|---|
| 01/02/2026 | Date of RSU settlement into common shares and grant of new RSUs. |
| 01/06/2026 | Date the Form 4 was signed by the Attorney-in-Fact. |
Recommendation
holdThis Form 4 filing details a routine insider transaction involving the conversion of Restricted Stock Units into common stock and the grant of new RSUs to a director. Such transactions are standard compensation practices and do not typically provide new fundamental information to warrant a change in investment recommendation. The increased direct ownership by a director is a minor positive for alignment, but not a catalyst for a 'buy' recommendation. No negative signals are present to suggest a 'sell'.
Keywords
Novanta Inc., NOVT, Form 4, Insider Transaction, Restricted Stock Units, Common Stock, Director, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.